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Most peripheral vascular reconstructions are asso- 
ciated with some degree of reflow hyperaemic 
response. For the majority, the phenomenon is self- 
limiting, not clinically harmful and may even repre- 
sent a positive predictor of outcome. However, this 
normally physiological response may become patho- 
logical due to its harmful sequellae on the down- 
stream vascular bed. In this regard, the post-carotid 
endarterectomy (CEA) hyperperfusion syndrome is an 
excellent example of how intrinsic and extrinsic 
factors may combine to effect severe clinical and 
pathological consequences in susceptible patients. 
Cerebral blood flow studies suggest hat most 
patients will have some degree of hyperaemia follow- 
ing CEA. This may be shortlived, for example after 
carotid clamp release, 1"2 or may develop over the first 
12-24 h and persist for days thereafter. 2-4 The vast 
majority will however remain asymptomatic. A
smaller proportion (perhaps 2-15%) will develop 
ipsilateral headache or seizures, but only 0.5-2% will 
progress towards infarct extension or intracerebral 
haemorrhage.2, 5-7 
Despite the apparently low incidence of hyper- 
perfusion-related stroke (the most important end- 
point), we feel that it should not simply be accepted as 
a rare but inevitable complication ofCEA. The reasons 
are fourfold. First, although the international trials 
have confirmed the benefits of CEA in selected 
patients, vascular surgeons must continue to reduce 
the initial operative risk. Second, it is possible that the 
relative incidence of hyperperfusion-related complica- 
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tions may increase as the proportion of patients with 
severe carotid stenoses and haemodynamic com- 
promise increases (see below). Third, although rare, 
intracerebral haemorrhage carries a mortality rate of 
36-60% and a death and/or disability rate of 80%. 5-7 
Finally, recent research suggests that it may now be 
possible to identify vulnerable patients to whom more 
intensive monitoring and interventional facilities can 
be directed. 
The pathophysiology of the post-CEA hyper- 
perfusion syndrome through to infarction or haemor- 
rhage is complex and multifactorial. The key phases 
towards understanding its progression include (i) 
recognition of vulnerable patients, (ii) defining the 
temporal relationship between cerebral haemody- 
namics, cerebral autoregulation, postoperative hyper- 
tension and the development of symptoms and finally 
(iii) investigating the microcirculatory changes that 
result in cerebral oedema, infarct extension and 
ultimately haemorrhage. To date, we have most 
information on the first category, some important new 
knowledge on the second, but little concerning the 
third. 
Research as shown that patients most at risk of 
developing a sustained post-operative hyperperfusion 
response are almost identical to those likely to suffer 
intracerebral haemorrhage. 2" 5-9 They are almost exclu- 
sively patients with the combination of a severe 
carotid stenosis (especially those with contralateral 
occlusion) and poor recruitment of collateral flow via 
the circle of Willis. 2' s Although cerebral blood flow is 
maintained at remarkably normal levels in the pres- 
ence of impaired inflow, this is at the expense of 
progressive pial arteriolar vasodilatation which is 
manifest preoperatively by reduced, absent or even 
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reversed CO2 reactivity. 2'3'8 In effect, the patients 
approach operation with pre-existing impairment of 
cerebral vascular reserve and defective autoregula- 
tion.2, 3 At operation, these patients have the highest 
pressure gradients over their stenoses 2'5 and the 
lowest stump pressures. 2 Postoperatively, the defect in 
autoregulation takes some days to "reset". During this 
time, the brain is unable to control the surge of blood 
through its already dilated arteries and the hyper- 
perfusion syndrome is thus underway. 2~ However, 
even though up to 30% of patients may have such a 
response, relatively few become symptomatic. 3 
Clearly, other factors must co-exist for the process to 
move from the physiological to the pathological. 
The classical primary symptoms of the hyper- 
perfusion syndrome include ipsilateral fronto-tempo- 
ral/peri-orbital headache and seizure. 5" 7, 8 The exact 
cause of the headache is unknown but could represent 
a migraine variant. Similarly, seizure could follow 
oedema, raised intracranial pressure or some local 
metabolic abnormality. Most reports on the sympto- 
matic post-CEA hyperperfusion syndrome (headache, 
seizure) regularly include details concerning co-exist- 
ing problems with blood pressure control. 2"5'7'8 
Patients can have symptoms in association with 
persistent elevation of blood pressure, 5 others become 
symptomatic in association with episodic rises in 
blood pressure, 5"7 while some have symptoms and 
normal blood pressure. 5' 8 To complicate matters fur- 
ther, Schroeder et al. have also reported a patient in 
whom blood flow was declining but who then 
developed symptoms when the blood pressure rose. 4 
There is some evidence that reduction of blood 
pressure by pharmacological means can abolish symp- 
toms and reduce middle cerebral artery (MCAV) 
velocity, 2 though the inter-relationship is complex. For 
example, reduction of blood pressure in post-CEA 
hypertension i  patients with a normal MCAV cor- 
rects the hypertension but does not reduce MCAV. But, 
if the patient has an elevated MCAV, a reduction in 
blood pressure does reduce MCAV (but only in the 
ipsilateral hemisphere) and symptoms may disappear 
after a reduction in blood pressure even in normo- 
tensive patients. 2 At present therefore, we do not 
understand the temporal relationship between flow, 
blood pressure, autoregulation and symptoms. How- 
ever, once the defect in autoregulation spontaneously 
L"resets" after about 5-7 days, the hyperperfusion 
response, surges in blood pressure and symptoms 
seem to abate. 2-4 
Headache is usually the first symptom to develop 
during the hyperperfusion syndrome (after 1-4 days), 
seizures tending to follow thereafter. 5' 7 Intracerebral 
haemorrhage or infarct extension tends to be a late 
occurrence, presumably reflecting progressive micro- 
circulatory changes beyond those required to cause 
headache or seizure. More recentl}5 Jansen et al. have 
shown that patients with a > 100% increase in MCAV 
following restoration of flow were significantly more 
likely to suffer late haemorrhage than patients with 
lesser increases in MCAV. 7 However, it remains 
unclear whether haemorrhage can occur in the 
absence of preceding hyperperfusion or symptoms. 
There is also little available information as to the 
causation of post-CEA oedema or micro-circulatory 
change beyond proposing increasing permeability, but 
histological studies at autopsy do not support the 
hypothesis that there is an underlying malignant 
hypertensive ncephalopathy. 5 Possible associations, 
explanations or predisposing factors to haemorrhagic 
transformation and/or cerebral oedema include a 
history of pre-operative hypertension, 8 abnormal 
coagulation, 9 pre-existing or recent cerebral infarc- 
tion 5, 7 or some metabolic influence such as the local 
release of vasodilators including adenosine, calcitonin 
gene related peptide and substance p.~O Moreover, will 
a reduction of blood pressure, thereby reducing 
MCAV, not only abolish symptoms but prevent haem- 
orrhage? At present, much will remain the preserve of 
scientific speculation until carefully controlled studies 
are available. 
The post-CEA hyperperfusion syndrome is 
clearly a complex phenomenon. Although we are 
becoming more aware of many aspects of its pathoge- 
nesis, there is still much basic and advanced scientific 
research to be done. With increasing knowledge, it is 
"hoped that more novel pharmacological pproaches 
such as membrane stabilisers and cytoprotective 
agents will become available. At present however, we 
can do little more than identify and monitor high risk 
patients and institute aggressive control of blood 
pressure, particularly at the first sign of symptoms. 
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